| IKBKB |
IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta |
HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
0.468 |
Evidence |
|
| PIK3CD |
PIK3CD: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta i |
HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
0.468 |
Evidence |
|
| PIK3CD |
PIK3CD: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta i |
HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
0.468 |
Evidence |
|
| SF3A1 |
SF3A1, SAP114: Splicing factor 3 subunit 1 |
SMURF2 |
SMURF2: E3 ubiquitin-protein ligase SMURF2 |
0.468 |
Evidence |
|
| DUSP4 |
DUSP4, MKP2, VH2: Dual specificity protein phosphatase 4 |
PTPRE |
PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor |
0.468 |
Evidence |
|
| KCNH2 |
KCNH2, ERG, ERG1, HERG, HERG1: Potassium voltage-gated channel subfamily H membe |
RAB11FIP2 |
RAB11FIP2, KIAA0941: Rab11 family-interacting protein 2 |
0.468 |
Evidence |
|
| DUSP2 |
DUSP2, PAC1: Dual specificity protein phosphatase 2 |
PTPRE |
PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor |
0.468 |
Evidence |
|
| RBL1 |
RBL1: Retinoblastoma-like protein 1 |
ERN2 |
ERN2, IRE2: Serine/threonine-protein kinase/endoribonuclease IRE2 precursor |
0.468 |
Evidence |
|
| TGFB3 |
TGFB3: Transforming growth factor beta-3 precursor |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
0.468 |
Evidence |
|
| GRIN2D |
GRIN2D, NMDAR2D: Glutamate [NMDA] receptor subunit epsilon-4 precursor |
PHC2 |
PHC2, EDR2, PH2: Polyhomeotic-like protein 2 |
0.468 |
Evidence |
|
| GNAI2 |
Galphai2 protein |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| CXCL12 |
Stromal cell-derived factor 1 delta |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| PCDHA2 |
PCDHA2: Protocadherin alpha 2 precursor |
VDP |
DKFZp451D234: Putative uncharacterized protein DKFZp451D234 |
0.468 |
Evidence |
|
| CCL26 |
CCL26, SCYA26, UNQ216/PRO242: Small-inducible cytokine A26 precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| CCL26 |
CCL26, SCYA26, UNQ216/PRO242: Small-inducible cytokine A26 precursor |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
0.468 |
Evidence |
|
| ALK |
ALK: ALK tyrosine kinase receptor precursor |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
0.468 |
Evidence |
|
| ALK |
ALK: ALK tyrosine kinase receptor precursor |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
0.468 |
Evidence |
|
| HSPB8 |
HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 |
CRYBA4 |
CRYBA4: Beta-crystallin A4 |
0.468 |
Evidence |
|
| MUCDHL |
MUPCDH, MUCDHL, UNQ2781/PRO7168: Mucin and cadherin-like protein precursor |
VDP |
DKFZp451D234: Putative uncharacterized protein DKFZp451D234 |
0.468 |
Evidence |
|
| TRPV4 |
TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb |
RYR1 |
|
0.468 |
Evidence |
|
| MCOLN1 |
MCOLN1, ML4, MSTP080: Mucolipin-1 |
TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
0.468 |
Evidence |
|
| MCOLN1 |
MCOLN1, ML4, MSTP080: Mucolipin-1 |
TRPV4 |
TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb |
0.468 |
Evidence |
|
| CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| RYR2 |
RYR2: Ryanodine receptor 2 |
TRPV4 |
TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb |
0.468 |
Evidence |
|
| RYR2 |
RYR2: Ryanodine receptor 2 |
TRPM7 |
TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me |
0.468 |
Evidence |
|